These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15191508)

  • 1. Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.
    Herrlinger KR; Fellermann K; Fischer C; Kreisel W; Deibert P; Schoelmerich J; Fleig WE; Ruhl A; Reinshagen M; Greinwald R; Stange EF; Schwab M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1269-76. PubMed ID: 15191508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's disease.
    de Boer NK; Derijks LJ; Keizer-Garritsen JJ; Lambooy LH; Ruitenbeek W; Hooymans PM; van Bodegraven AA; de Jong DJ
    J Clin Pharmacol; 2007 Feb; 47(2):187-91. PubMed ID: 17244769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
    Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
    Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
    Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B
    Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment.
    de Boer NK; de Graaf P; Wilhelm AJ; Mulder CJ; van Bodegraven AA
    Aliment Pharmacol Ther; 2005 Sep; 22(5):447-51. PubMed ID: 16128683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.
    Andoh A; Tsujikawa T; Ban H; Hashimoto T; Bamba S; Ogawa A; Sasaki M; Saito Y; Fujiyama Y
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
    Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
    Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
    Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.
    Almer SH; Hjortswang H; Hindorf U
    Dig Liver Dis; 2009 Mar; 41(3):194-200. PubMed ID: 18799369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
    Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
    Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients.
    Gilissen LP; Bierau J; Derijks LJ; Bos LP; Hooymans PM; van Gennip A; Stockbrügger RW; Engels LG
    Aliment Pharmacol Ther; 2005 Oct; 22(7):605-11. PubMed ID: 16181300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring 6-thioguanine nucleotide concentrations in Japanese children and adolescents with inflammatory bowel disease.
    Ohtsuka Y; Arai K; Aoyagi Y; Fujii T; Yamakawa Y; Ohtani K; Ikuse T; Baba Y; Inage E; Kudo T; Suzuki R; Nagata S; Shimizu T
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1626-30. PubMed ID: 20880170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease.
    Goldenberg BA; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 2004 Sep; 99(9):1744-8. PubMed ID: 15330913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioguanine nucleotides and thiopurine methyltransferase in immunobullous diseases: optimal levels as adjunctive tools for azathioprine monitoring.
    el-Azhary RA; Farmer SA; Drage LA; Rogers RS; McEvoy MT; Davis MD; Bridges AG; Gibson LE
    Arch Dermatol; 2009 Jun; 145(6):644-52. PubMed ID: 19528417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.
    González-Lama Y; Bermejo F; López-Sanromán A; García-Sánchez V; Esteve M; Cabriada JL; McNicholl AG; Pajares R; Casellas F; Merino O; Carpio D; Vera MI; Muñoz C; Calvo M; Benito LM; Bujanda L; García-Fernández FJ; Ricart E; Ginard D; Velasco M; Carneros JA; Manceñido N; Calvo M; Algaba A; Froilan C; Cara C; Maté J; Abreu L; Gisbert JP;
    Aliment Pharmacol Ther; 2011 Sep; 34(5):544-54. PubMed ID: 21722149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-Thioguanine Nucleotide Levels Are Associated With Mucosal Healing in Patients With Crohn's Disease.
    Mao R; Guo J; Luber R; Chen BL; He Y; Zeng ZR; Ben-Horin S; Sparrow MP; Roblin X; Chen MH
    Inflamm Bowel Dis; 2018 Nov; 24(12):2621-2627. PubMed ID: 29788262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
    Angelberger S; Schaeffeler E; Teml A; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR; Schwab M; Reinisch W
    Inflamm Bowel Dis; 2013 Mar; 19(3):590-8. PubMed ID: 23388543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients.
    Liu Q; Wang Y; Mei Q; Han W; Hu J; Hu N
    Scand J Gastroenterol; 2016 Sep; 51(9):1093-9. PubMed ID: 27152547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.